Cardinal Health delivered 5% and 28% revenue and adjusted EPS growth, respectively, during the first fiscal quarter, above FactSet consensus estimates. Full-year guidance for both was raised a low single-digit percentage.
Cardinal Health distributes pharmaceutical products to nearly one third of the industry, leading to substantial negotiation leverage with generic drug manufacturers.
Reimbursement pressures on pharmacy and provider customers have led to an emphasis on cost containment, pressuring Cardinal Health’s profitability.
Metric | CAH | MCK | COR |
|---|---|---|---|
Price/Earnings (Normalized) | 23.79 | 25.78 | 19.81 |
Price/Book Value | — | — | 17.61 |
Price/Sales | 0.24 | 0.31 | 0.20 |
Price/Cash Flow | 17.28 | 19.05 | 16.06 |
Metric | CAH | MCK | COR |
|---|---|---|---|
Quick Ratio | 0.43 | 0.50 | 0.48 |
Current Ratio | 0.88 | 0.90 | 0.93 |
Interest Coverage | 7.64 | 22.07 | 7.89 |
Metric | CAH | MCK | COR |
|---|---|---|---|
Return on Assets (Normalized) | 4.78% | 5.95% | 4.24% |
Return on Equity (Normalized) | — | — | 141.22% |
Return on Invested Capital (Normalized) | 48.63% | 56.87% | 30.10% |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| McKesson Corp MCK | LOCK|kxvbs? | LOCK|x?%# | $124B | |||
| Cencora Inc COR | LOCK|SN&##ZP | LOCK|mCGrz | $65B | |||
| Sigma Healthcare Ltd SIGGF | — | LOCK|V>bKL | $23B | |||
| Henry Schein Inc HSIC | LOCK|@Z>?&r | LOCK|<f>$D | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR SHPMY | — | LOCK|KKx | $8B | |||
| Sinopharm Group Co Ltd SHTDF | — | LOCK|p^ | $7B | |||
| Sinopharm Group Co Ltd ADR SHTDY | — | LOCK|DF | $7B | |||
| Galenica Ltd GALNF | — | LOCK|D!<<k | $6B | |||
| Medipal Holdings Corp MEPDF | — | LOCK|jY | $5B |
United States